Boardroom Alpha
Meeting calendar
DVA · Annual meeting · Thursday, June 4, 2026

Davita Inc

9 nominees · 3 ballot items.

Election of nine directors; ratification of KPMG LLP as independent auditor for fiscal year 2026; and an advisory (non-binding) say-on-pay vote to approve named executive officer compensation.

Market cap
$15.0B
1Y TSR
+55.3%
Board grade
B
Record date
Apr 9, 2026
Filing
DEF 14A
Meeting concluded · Jun 4, 2026

Follow how the vote landed and what changed on Davita Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect nine director nominees each to serve until the 2027 Annual Meeting or until their successors are duly elected and qualified.

  2. 2

    Ratification of Appointment of Independent Registered Public Accounting Firm (KPMG LLP

    ManagementBoard: FOR

    Ratify the Audit Committee’s appointment of KPMG LLP as DaVita’s independent registered public accounting firm for fiscal year 2026.

  3. 3

    Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay

    ManagementBoard: FOR

    An advisory, non-binding vote to approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.

    More detail

    This proposal asks stockholders to cast an advisory (non-binding) vote approving the Company’s named executive officer (NEO) compensation as disclosed in the Proxy Statement. Management is seeking shareholder approval to confirm that its compensation design — which emphasizes a high proportion of at-risk pay tied to short-term and long-term performance metrics (including Adjusted Operating Income, Free Cash Flow, Adjusted EPS and Relative TSR), and a mix of PSUs, RSUs and SSARs — aligns executives’ incentives with the Company’s strategic objectives and stockholder interests. The Compensation Committee frames the program as pay-for-performance with formulaic STI and PSU metrics, and retains limited discretion only to apply negative adjustments; it also emphasizes share ownership requirements, clawback policies, double-trigger change-of-control provisions and other governance features. The context includes recent operational developments (IKC profitability, international expansion, cybersecurity incident response) and strong stockholder engagement and prior high say-on-pay votes, which management cites to justify continuation of the program. The vote is advisory and non-binding, but the Board and Compensation Committee commit to considering the results when making future compensation decisions. A failure to approve would not automatically change pay arrangements but would likely trigger heightened engagement with major investors and could prompt the Compensation Committee to redesign elements of the program to better reflect stockholder concerns. Given the company’s disclosure of robust performance metrics, multi-year incentives, and safeguards against excessive risk-taking, the Board recommends a FOR vote because it believes approval supports continuity of an executive compensation framework that it views as focused on long-term value creation and alignment with stockholders. The analysis for sophisticated investors should weigh the program’s heavy reliance on equity-based awards (sensitive to stock price movements), the mechanics of PSU adjustments (including permitted pre-established adjustments), and the broader governance practices (independent Compensation Committee, independent chair, recoupment policies) when assessing whether the advisory endorsement appropriately reflects stockholder interests.

Director elections

Nominees on the ballot9

Independent
Tenure on this board
17.1 yrs
Also a director at
Iron Mountain Inc (IRM)
Independent
Tenure on this board
4.2 yrs
Also a director at
Cardinal Health Inc (CAH)
Not independent
Tenure on this board
7.1 yrs
Also a director at
Gilead Sciences Inc (GILD)
Independent
Tenure on this board
3.8 yrs
Also a director at
Labcorp Holdings Inc (LH)
Independent
Tenure on this board
3.0 yrs
Also a director at
Fossil Group Inc (FOSL)
Independent
Tenure on this board
10.0 yrs
Also a director at
Bristol Myers Squibb Co (BMY)
Ownership

Top institutional holders10

Latest 13F quarter
1BERKSHIRE HATHAWAY INC23.6%15,126,977$2.3B
2BERKSHIRE HATHAWAY INC23.3%14,973,608$2.3B
3VANGUARD CAPITAL MANAGEMENT LLC3.4%2,180,225$335M
4VANGUARD PORTFOLIO MANAGEMENT LLC2.3%1,479,600$227M
5STATE STREET CORP2.1%1,351,737$208M
6Invesco Ltd.2.1%1,324,364$204M
7BlackRock, Inc.2.1%1,322,480$203M
8ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.7%1,110,151$171M
9DIMENSIONAL FUND ADVISORS LP1.7%1,065,322$164M
10LSV ASSET MANAGEMENT1.5%931,058$143M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Davita Inc 2026 annual meeting?
Davita Inc (DVA) holds its 2026 annual shareholder meeting on Thursday, June 4, 2026.
What is the record date for the Davita Inc 2026 meeting?
The record date for the Davita Inc 2026 meeting is Thursday, April 9, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Davita Inc's 2026 meeting?
The board is presenting 9 director nominees at the Davita Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Davita Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Davita Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer